||
中国科学院广州生物医药与健康研究院刘劲松课题组近日解析了Nurr1多结构域结合DNA的结构,是核受体领域第一个单体多结构域晶体结构,并进一步利用整合结构生物学方法研究了Nurr1受DNA和配体RXRα调控的分子机制。相关研究成果以Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer为题发表在PNAS上。https://www.ebiotrade.com/newsf/2022-12/20221208065256280.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=a20579ca-3a97-424e-a439-ed32039a0165
01. | 无法确认 | 1 篇 | 4.545% |
02. | 2022 | 1 篇 | 4.545% |
03. | 2021 | 2 篇 | 9.091% |
04. | 2019 | 4 篇 | 18.182% |
05. | 2018 | 3 篇 | 13.636% |
06. | 2016 | 1 篇 | 4.545% |
07. | 2015 | 2 篇 | 9.091% |
08. | 2013 | 2 篇 | 9.091% |
09. | 2012 | 1 篇 | 4.545% |
10. | 2011 | 3 篇 | 13.636% |
01. | acs chem neurosci | 1 篇 | 4.545% |
02. | arch pharm (weinheim) | 1 篇 | 4.545% |
03. | biochem pharmacol | 1 篇 | 4.545% |
04. | biochim biophys acta | 1 篇 | 4.545% |
05. | biochim biophys acta gen subj | 1 篇 | 4.545% |
06. | bioorg med chem lett | 1 篇 | 4.545% |
07. | chem biol drug des | 1 篇 | 4.545% |
08. | comput biol chem | 1 篇 | 4.545% |
09. | crit rev biochem mol biol | 1 篇 | 4.545% |
10. | curr drug discov technol | 1 篇 | 4.545% |
01. | 美国 | 9 篇 | 40.909% |
02. | 德国 | 3 篇 | 13.636% |
03. | 加拿大 | 3 篇 | 13.636% |
04. | 中国 | 2 篇 | 9.091% |
05. | 爱尔兰 | 1 篇 | 4.545% |
06. | 法国 | 1 篇 | 4.545% |
07. | 韩国 | 1 篇 | 4.545% |
08. | 瑞士 | 1 篇 | 4.545% |
09. | 西班牙 | 1 篇 | 4.545% |
10. | 意大利 | 1 篇 | 4.545% |
01. | 中国上海 | 1 篇 | 4.545% |
02. | 中国潍坊 | 1 篇 | 4.545% |
03. | 中国武汉 | 1 篇 | 4.545% |
01. | Humans | 15 篇 | 68.182% |
02. | Animals | 8 篇 | 36.364% |
03. | Allosteric Regulation | 7 篇 | 31.818% |
04. | Structure-Activity Relationship | 7 篇 | 31.818% |
05. | Allosteric Site | 5 篇 | 22.727% |
06. | Protein Binding | 5 篇 | 22.727% |
07. | HEK293 Cells | 4 篇 | 18.182% |
08. | Molecular Structure | 4 篇 | 18.182% |
09. | Binding Sites | 3 篇 | 13.636% |
10. | Molecular Dynamics Simulation | 3 篇 | 13.636% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-4-19 10:08
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社